TERIPARATIDE VERSUS ALENDRONATE FOR TREATING GLUCOCORTICOID-INDUCED OSTEOPOROSIS: 36-MONTH RESULTS

被引：0
|
作者：
Devogelaer, J. -P. [1 ]
Warner, M. [2 ]
Saag, K. [3 ]
Zanchetta, J. [4 ]
Adler, R. [5 ]
Eastell, R. [6 ]
See, K. [2 ]
Dalsky, G. [2 ]
Krohn, K. [2 ]
Krege, J. [2 ]
机构：
[1] St Luc Univ Hosp, Arthritis Unit, Brussels, Belgium
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] Univ Alabama, Birmingham, AL USA
[4] IDIM, Buenos Aires, DF, Argentina
[5] McGuire VA Med Ctr, Richmond, VA USA
[6] Univ Sheffield, Acad Unit Bone Metab, Sheffield, S Yorkshire, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Teriparatide versus alendronate for treatment of glucocorticoid-induced osteoporosis: 36-month results
    Saag, Kenneth G.
    Zanchetta, Jose R.
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Eastell, Richard
    See, Kyoungah
    Dalsky, Gail P.
    Krohn, Kelly
    Krege, John H.
    Warner, Margaret R.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S939 - S939
  • [2] Teriparatide versus Alendronate for Treatment of Glucocorticoid-Induced Osteoporosis: 36-month Results
    Saag, K. G.
    Zanchetta, J. R.
    Devogelaer, J. P.
    Adler, R. A.
    See, K.
    Dalsky, G. P.
    Krohn, K.
    Krege, J. H.
    Warner, M. R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S49 - S49
  • [3] Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Babb, Richard R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12): : 1302 - 1303
  • [4] Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Saag, Kenneth G.
    Shane, Elizabeth
    Boonen, Steven
    Marin, Fernando
    Donley, David W.
    Taylor, Kathleen A.
    Dalsky, Gail P.
    Marcus, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20): : 2028 - 2039
  • [5] Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
    Langdahl, B. L.
    Marin, F.
    Shane, E.
    Dobnig, H.
    Zanchetta, J. R.
    Maricic, M.
    Krohn, K.
    See, K.
    Warner, M. R.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (12) : 2095 - 2104
  • [6] Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
    B. L. Langdahl
    F. Marin
    E. Shane
    H. Dobnig
    J. R. Zanchetta
    M. Maricic
    K. Krohn
    K. See
    M. R. Warner
    Osteoporosis International, 2009, 20 : 2095 - 2104
  • [7] Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial
    Saag, Kenneth G.
    Zanchetta, Jose R.
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Eastell, Richard
    See, Kyoungah
    Krege, John H.
    Krohn, Kelly
    Warner, Margaret R.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3346 - 3355
  • [8] Is teriparatide or alendronate the best treatment for glucocorticoid-induced osteoporosis?
    Woolf, Anthony D.
    Akesson, Kristina
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (05): : 236 - 237
  • [9] Is teriparatide or alendronate the best treatment for glucocorticoid-induced osteoporosis?
    Anthony D Woolf
    Kristina Åkesson
    Nature Clinical Practice Rheumatology, 2008, 4 : 236 - 237
  • [10] Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis
    Saag, K. G.
    Shane, E.
    Boonen, S.
    Donley, D. W.
    Marin, F.
    Warner, M. R.
    Taylor, K. A.
    Dalsky, G. R.
    Marcus, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 117 - 117
12345